Data / Form D filings / RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS, INC.: Form D filings
RECURSION PHARMACEUTICALS, INC., a pharmaceuticals company in Salt Lake City, UT, filed 12 Form D notices with the SEC between 2014 and 2020. The latest, on November 12, 2020, reports $245.9 million sold of a $245.9 million offering to 49 investors.
Find out what RECURSION PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 41S RIO GRANDE STREET, Salt Lake City, UT, 84101
- Phone
- (385) 269-0203
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1601830
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2020 | Amendment | $245,896,677 | $245,896,677 | $0 | 49 | Sep 1, 2020 | sec.gov |
| Sep 15, 2020 | New notice | $235,506,731 | $235,506,731 | $0 | 38 | Sep 1, 2020 | sec.gov |
| Aug 13, 2019 | New notice | $122,057,689 | $122,057,689 | $0 | 33 | Feb 12, 2019 | sec.gov |
| Oct 6, 2017 | New notice | $59,999,975 | $55,799,946 | $4,200,029 | 26 | Sep 25, 2017 | sec.gov |
| Dec 2, 2016 | Amendment | $15,034,984 | $15,034,984 | $0 | 18 | Sep 2, 2016 | sec.gov |
| Sep 14, 2016 | New notice | $12,909,987 | $12,909,987 | $0 | 13 | Sep 2, 2016 | sec.gov |
| Sep 14, 2016 | New notice | $32,000,000 | $32,000,000 | $0 | 32 | Sep 1, 2016 | sec.gov |
| Sep 14, 2016 | New notice | $4,066,996 | $4,066,996 | $0 | 31 | Sep 1, 2016 | sec.gov |
| Dec 4, 2015 | New notice | $2,700,000 | $2,650,000 | $50,000 | 8 | Nov 20, 2015 | sec.gov |
| Feb 23, 2015 | New notice | $1,000,000 | $830,000 | $170,000 | 19 | Feb 17, 2015 | sec.gov |
| Apr 2, 2014 | Amendment | $200,000 | $80,000 | $120,000 | 5 | Mar 19, 2014 | sec.gov |
| Apr 2, 2014 | New notice | $200,000 | $80,000 | $120,000 | 5 | Mar 19, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| ROBERT C. HERSHBERG | Director | |
| R. MARTIN CHAVEZ | Director | |
| MICHAEL MARTIN SECORA | Executive Officer, Promoter | |
| DEAN C. LI | Director | |
| ZACHARY C. BOGUE | Director | |
| ZAVAIN C. DAR | Director | |
| BLAKE C. BORGESON | Director | |
| CHRISTOPHER C. GIBSON | Executive Officer, Director, Promoter | |
| TERRY-ANN C. BURRELL | Director |
Every Form D from the week of Nov 9, 2020 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RECURSION PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.